Evidence map›Paper›PMID 28329184›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

The Causal Effect of Tracing by Peer Health Workers on Return to Clinic Among Patients Who Were Lost to Follow-up From Antiretroviral Therapy in Eastern Africa: A "Natural Experiment" Arising From Surveillance of Lost Patients.

Anna Bershetyn, Thomas A Odeny, Rita Lyamuya, Alice Nakiwogga-Muwanga, Lameck Diero, Mwebesa Bwana, Paula Braitstein, Geoffrey Somi, Andrew Kambugu, Elizabeth Bukusi and 7 more

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06803316 (Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06803316 completednot on this mapstarted 2022, after this paper: background citation

Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia

Typeobservational_patient_registrySponsorCentre for Infectious Disease Research in ZambiaRan2022 to 2025Enrolled658ConditionsHIV Antiretroviral Therapy (ART) Adherence
3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Anna BershetynInstitute for Disease Modeling, Bellevue, Washington.
Thomas A OdenyKenya Medical Research Institute, Nairobi.
Rita LyamuyaNational AIDS Control Program, Dar es Salaam, Tanzania.
Alice Nakiwogga-MuwangaInfectious Diseases Institute, Kampala, Uganda.
Lameck DieroUnited States Agency for International Development-Academic Partnership Program, Eldoret, Kenya.
Mwebesa BwanaDepartment of Epidemiology and Biostatistics, University of California, San Francisco.
Paula BraitsteinUnited States Agency for International Development-Academic Partnership Program, Eldoret, Kenya.
Geoffrey SomiNational AIDS Control Program, Dar es Salaam, Tanzania.
Andrew KambuguInfectious Diseases Institute, Kampala, Uganda.
Elizabeth BukusiKenya Medical Research Institute, Nairobi.
Wendy HartogensisDivision of HIV/AIDS, Department of Medicine, San Francisco General Hospital, California.
David V GliddenDepartment of Epidemiology and Biostatistics, University of California, San Francisco.
Kara Wools-KaloustianDivision of Infectious Diseases, Department of Medicine, and.
Constantin YiannoutsosDepartment of Biostatistics, Fairbanks School of Public Health, Indiana University, Indianapolis.
Jeffrey MartinDepartment of Epidemiology and Biostatistics, University of California, San Francisco.
Elvin H GengDivision of HIV/AIDS, Department of Medicine, San Francisco General Hospital, California.
East Africa International Epidemiologic Databases to Evaluate AIDS (EA-IeDEA) Consortium

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional ConsortiumU01AI069911 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Leslie Anne Enane, AGGREY SEMWENDERO SEMEERE · 2006 to 2026
$57.7M
NIAID NIH HHS P30 AI027763NIAID NIH HHS U01 AI069911
6 · The paper itself

Abstract

BACKGROUND.: The effect of tracing human immunodeficiency virus (HIV)-infected patients who are lost to follow-up (LTFU) on reengagement has not been rigorously assessed. We carried out an ex post analysis of a surveillance study in which LTFU patients were randomly selected for tracing to identify the effect of tracing on reengagement. METHODS.: We evaluated HIV-infected adults on antiretroviral therapy who were LTFU (>90 days late for last visit) at 14 clinics in Uganda, Kenya, and Tanzania. A random sample of LTFU patients was selected for tracing by peer health workers. We assessed the effect of selection for tracing using Kaplan-Meier estimates of reengagement among all patients as well as the subset of LTFU patients who were alive, contacted in person by the tracer, and out of care. RESULTS.: Of 5781 eligible patients, 991 (17%) were randomly selected for tracing. One year after selection for tracing, 13.3% (95% confidence interval [CI], 11.1%-15.3%) of those selected for tracing returned compared with 10.0% (95% CI, 9.1%-10.8%) of those not randomly selected, an adjusted risk difference of 3.0% (95% CI, .7%-5.3%). Among patients found to be alive, personally contacted, and out of care, tracing increased the absolute probability of return at 1 year by 22% (95% CI, 7.1%-36.2%). The effect of tracing on rate of return to clinic decayed with a half-life of 7.0 days after tracing (95% CI, 2.6 %-12.9%). CONCLUSIONS.: Tracing interventions increase reengagement, but developing methods for targeting LTFU patients most likely to benefit can make this practice more efficient.

Indexed as

Epidemiological MonitoringLost to Follow-UpAdultAmbulatory Care FacilitiesAnti-HIV AgentsFemaleHealth PersonnelHIV InfectionsHumansKenyaMaleTanzaniaUgandaAnti-HIV AgentsAfricaantiretroviral therapyloss to follow-up.retention

Identifiers

PMID28329184
PMCPMC5848300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.